IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Commodore Capital LP

Portfolio Profile

CIK: 0001831942 | NEW YORK, NY

Investment Profile

Style

Value

Turnover

Medium

Orientation

Concentrated trader
$1.7B
AUM
33
Positions
68.18%
Top 10 Conc.
96.69%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Relay Therapeutics Inc(RLAY)12,000,000$224.5M13.37%
2Enliven Therapeutics Inc(ELVN)3,275,000$166.2M9.90%
3Alkermes PLC(ALKS)3,000,000$157.2M9.36%
4Cogent Biosciences Inc(COGT)3,050,000$118.0M7.03%
5Amylyx Pharmaceuticals Inc(AMLX)5,650,000$101.5M6.04%

Sector Allocation

Latest filing, equity positions only

Healthcare94.31% · $1.6B
Unclassified5.69% · $95.5M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare95.45%94.31%-1.14%
Unclassified4.55%5.69%+1.14%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$855.5M | 30 pos.
$1.1B | 32 pos.
$1.5B | 39 pos.
$1.5B | 35 pos.
$1.6B | 36 pos.
$1.4B | 31 pos.
6
Definium Therapeutics Inc(DFTX)
2,000,000
$94.1M
5.60%
7Spyre Therapeutics Inc(SYRE)846,786$75.2M4.48%
8Alto Neuroscience Inc(ANRO)2,723,196$71.9M4.28%
9Tango Therapeutics Inc(TNGX)2,250,000$70.3M4.19%
10Eyepoint Inc(EYPT)4,600,000$65.8M3.92%
Cap SizePrev %Curr %Change
Small Cap48.86%52.35%+3.49%
Mid Cap42.58%36.67%-5.91%
Unclassified4.55%5.69%+1.14%
Micro Cap4.01%5.29%+1.28%
$1.4B | 31 pos.
$1.4B | 33 pos.
$2.0B | 37 pos.
$1.5B | 33 pos.
$1.7B | 36 pos.
$1.7B | 33 pos.
Q3
23
Q4
23
Q1
24
Q2
24
Q3
24
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

5
New
8
Closed
6
Increased
9
Decreased
13
Unchanged